Neurotech Pharmaceuticals
13 clinical trials · Sponsor
◉ Watch Neurotech Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants (NCT06971939) | Neurotech Pharmaceuticals | 2025-11-21 |
| A Study to Determine the Safety and Efficacy of NT-501 With MHFM (NCT06397131) | Neurotech Pharmaceuticals | 2025-03-06 |
| Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2 (NCT04729972) | Neurotech Pharmaceuticals | 2021-07-21 |
| A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B (NCT03319849) | Neurotech Pharmaceuticals | 2018-01-22 |
| A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A (NCT03316300) | Neurotech Pharmaceuticals | 2017-11-24 |
Track Neurotech Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.